Application
Western blot analysis of extracts from NIH-3T3 cells, treated with etoposide 25uM 1h, using MMP12 (Cleaved-Glu106) Antibody. The lane on the right is treated with the synthesized peptide.| Product Name | MMP12 (cleaved Glu106) antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Rabbit polyclonal antibody to MMP12 (cleaved Glu106)May be involved in tissue injury and remodeling. Has significant elastolytic activity. Can accept large and small amino acids at the P1' site, but has a preference for leucine. Aromatic or hydrophobic residues are preferred at the P1 site, with small hydrophobic residues (preferably alanine) occupying P3. |
| Immunogen | The antiserum was produced against synthesized peptide derived from human MMP12. |
| Clonality | Polyclonal |
|---|---|
| Host Species | Rabbit |
| Tested Applications | ELISAWB |
| ELISA: 1:20000Optimal dilutions should be determined experimentally by the end user.: |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Gene Synonyms | MMP12 MGC138506 MME HME MMP12 (cleaved E106) MMP12 (cleaved Glu106) MMP12 cleaved E106 MMP12 cleaved Glu106 Cleaved MMP12 (E106) Cleaved MMP12 (Glu106) |
|---|---|
| Target | MMP12 |
| Molecular Weight(MW) | 42 kDa (note) |
| Tissue Specificity | MMP12 (Cleaved-Glu106) Antibody detects endogenous levels of fragment of activated MMP12 resulting from cleavage adjacent to Glu106. |
Application
Western blot analysis of extracts from NIH-3T3 cells, treated with etoposide 25uM 1h, using MMP12 (Cleaved-Glu106) Antibody. The lane on the right is treated with the synthesized peptide.| Application Notes | ELISA: 1:20000Optimal dilutions should be determined experimentally by the end user.: |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | Store at -20 degrees Celcius. Product is stable for at least 1 year. |
| Storage Buffer | Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
